Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Müllerian agenesis: an update

E Lindenman1, M K Shepard, O H Pescovitz

  • 1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA.

Obstetrics and Gynecology
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification and localization of secretin and secretin receptor mRNAs in rat testis.

Endocrine·2010
Same author

Peptides of the growth hormone-releasing hormone family : Differential expression in rat testis.

Endocrine·2010
Same author

Advances in the treatment of precocious puberty.

Expert opinion on investigational drugs·2002
Same author

Peptides derived from pro-growth hormone-releasing hormone activate p38 mitogen-activated protein kinase in GH3 pituitary cells.

Endocrine·2001
Same author

Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone.

Endocrine·2001
Same author

Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.

Clinical pharmacology and therapeutics·2001
Same journal

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026
Same journal

Milestones in Motion: Vaginal Birth After Cesarean.

Obstetrics and gynecology·2026
Same journal

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
See all related articles

Müllerian agenesis etiology is unclear. Activating mutations in the antimüllerian hormone gene or its receptor may cause this condition in genetic females, impacting sexual differentiation.

Area of Science:

  • Reproductive biology
  • Developmental biology
  • Genetics

Background:

  • Recent advances in sexual differentiation research include identifying genes for antimüllerian hormone (AMH) and its receptor.
  • The underlying causes of müllerian agenesis, a clinical syndrome, remain largely unknown.
  • Sexual differentiation involves complex hormonal and genetic signaling pathways.

Purpose of the Study:

  • To hypothesize the genetic basis of müllerian agenesis.
  • To explore the potential role of activating mutations in AMH or its receptor genes.
  • To discuss current management strategies for müllerian agenesis.

Main Methods:

  • Review of current literature on sexual differentiation and müllerian agenesis.
  • Hypothetical model proposing gene mutations as a cause.

Related Experiment Videos

  • Discussion of established clinical management techniques.

    • Main Results:

    • The etiology of müllerian agenesis is not definitively established.
    • A hypothesis is proposed: activating mutations in AMH or AMH receptor genes may lead to müllerian duct regression.
    • Current management includes surgical (Abbe-McIndoe) and non-surgical (Frank vaginal dilation) methods.

    Conclusions:

    • Activating mutations in the antimüllerian hormone pathway are a plausible cause of müllerian agenesis.
    • Further research is needed to confirm the genetic etiology.
    • Effective management strategies exist for the clinical manifestations of müllerian agenesis.